{"id":62427,"date":"2025-12-31T19:05:52","date_gmt":"2025-12-31T18:05:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/"},"modified":"2025-12-31T19:05:52","modified_gmt":"2025-12-31T18:05:52","slug":"sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/","title":{"rendered":"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5655753\/sysmex-corp-6869-product-pipeline-analysis?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=3sbz55&amp;utm_campaign=2125100+-+Sysmex+Corp+(6869)+Product+Pipeline+Analysis+Report+2025%3A+Haematology%2C+Haemostasis%2C+and+Urinalysis+Analyzers&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">&#8220;Sysmex Corp (6869) &#8211; Product Pipeline Analysis, 2025 Update&#8221;<\/a> company profile has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands.<\/p>\n<p>\nSysmex Corp (Sysmex) is a provider of medical devices that researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. It offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing.<\/p>\n<p>\nThe company&#8217;s offerings include haematology, haemostasis, and urinalysis analyzers. Its products are used by medical institutions. It conducts research and development at its facilities in Japan, France, New Zealand, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa and Asia Pacific. Sysmex is headquartered in Hyogo, Japan.<\/p>\n<p>\nThe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.<\/p>\n<p>\n<strong>Report Scope:<\/strong><\/p>\n<ul>\n<li>\nThe report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments<\/li>\n<li>\nThe report analyzes all pipeline products in development for the company Sysmex Corp<\/li>\n<li>\nThe report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)<\/li>\n<li>\nThe report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date<\/li>\n<li>\nThe report provides detailed description of products in development, technical specification and functions<\/li>\n<li>\nThe report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.<\/li>\n<\/ul>\n<p>\n<strong>Sysmex Corp, Recent Developments<\/strong><\/p>\n<ul>\n<li>\nDec 15, 2025: A compact model has been added to the CN series<\/li>\n<li>\nDec 11, 2025: Sysmex Introduces Compact Model to CN-Series<\/li>\n<li>\nNov 24, 2025: Revolutionising UTIs Diagnosis and Treatment in 45 Minutes<\/li>\n<li>\nNov 04, 2025: Sysmex Introduces Two Testing Parameters for Hypertension Immunoassay Panel in Japan<\/li>\n<li>\nOct 10, 2025: Cytocell Received CLIA Approval for CytoCell KMT2A Breakapart FISH Probe Kit PDx<\/li>\n<li>\nOct 01, 2025: Sysmex Partners with QIAGEN for Exclusive Distribution and Supply of Clinical Diagnostic Products in Infectious Diseases and Oncology in Japan<\/li>\n<li>\nOct 01, 2025: Sysmex and QIAGEN Enter Strategic Alliance for Clinical Diagnostic Product Distribution in Japan<\/li>\n<li>\nSep 30, 2025: Cytocell Receives DeNovo Clearance for CytoCell KMT2A Breakapart FISH Probe Kit PDx<\/li>\n<li>\nSep 25, 2025: CytoCell KMT2A Breakapart FISH Probe Kit PDx Receives U.S. FDA Premarket Authorization (De Novo) &#8211; Contributing to Expanded Treatment Opportunities for Patients with Acute Leukemia &#8211; (OGT)<\/li>\n<li>\nSep 22, 2025: OGT Companion Diagnostic Receives FDA Approval for Identifying Acute Leukaemia Patients with KMT2Ar<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<ul>\n<li>\nSysmex Corp Company Overview<\/li>\n<li>\nSysmex Corp Company Snapshot<\/li>\n<li>\nSysmex Corp Pipeline Products and Ongoing Clinical Trials Overview<\/li>\n<li>\nSysmex Corp &#8211; Pipeline Analysis Overview<\/li>\n<li>\nBusiness Description<\/li>\n<li>\nSysmex Corp &#8211; Key Facts<\/li>\n<li>\nSysmex Corp &#8211; Major Products and Services<\/li>\n<li>\nSysmex Corp Pipeline Products by Development Stage<\/li>\n<li>\nSysmex Corp Pipeline Products Overview<\/li>\n<li>\nAntigen Saliva Test &#8211; COVID-19<\/li>\n<li>\nAntigen Saliva Test &#8211; COVID-19 Product Overview<\/li>\n<li>\nAntigen Test &#8211; COVID-19<\/li>\n<li>\nAntigen Test &#8211; COVID-19 Product Overview<\/li>\n<li>\nBlood-based Diagnostic Assay &#8211; Cancer<\/li>\n<li>\nBlood-based Diagnostic Assay &#8211; Cancer Product Overview<\/li>\n<li>\nCancer Diagnostic Reagent<\/li>\n<li>\nCancer Diagnostic Reagent Product Overview<\/li>\n<li>\nCancer Related Gene Panel Test System<\/li>\n<li>\nCancer Related Gene Panel Test System Product Overview<\/li>\n<li>\nCaptiver System<\/li>\n<li>\nCaptiver System Product Overview<\/li>\n<li>\nCompanion Diagnostic DNA Test<\/li>\n<li>\nCompanion Diagnostic DNA Test Product Overview<\/li>\n<li>\nDiagnostic Assay &#8211; Colorectal Cancer<\/li>\n<li>\nDiagnostic Assay &#8211; Colorectal Cancer Product Overview<\/li>\n<li>\nDiagnostic Test &#8211; Atopic Dermatitis<\/li>\n<li>\nDiagnostic Test &#8211; Atopic Dermatitis Product Overview<\/li>\n<li>\nDiagnostic Test &#8211; Liver Fibrosis<\/li>\n<li>\nDiagnostic Test &#8211; Liver Fibrosis Product Overview<\/li>\n<li>\nDiagnostic Test &#8211; Pancreatic Cancer<\/li>\n<li>\nDiagnostic Test &#8211; Pancreatic Cancer Product Overview<\/li>\n<li>\nFully Automatic Blood and Body Fluid Analyzer XR-10[B1]<\/li>\n<li>\nFully Automatic Blood and Body Fluid Analyzer XR-10[B1] Product Overview<\/li>\n<li>\nFully Automatic Blood and Body Fluid Analyzer XR-10[B2]<\/li>\n<li>\nFully Automatic Blood and Body Fluid Analyzer XR-10[B2] Product Overview<\/li>\n<li>\nFully Automatic Blood and Body Fluid Analyzer XR-10[B3]<\/li>\n<li>\nFully Automatic Blood and Body Fluid Analyzer XR-10[B3] Product Overview<\/li>\n<li>\nHISCL Blood Based Test &#8211; Alzheimer&#8217;s Disease<\/li>\n<li>\nHISCL Blood Based Test &#8211; Alzheimer&#8217;s Disease Product Overview<\/li>\n<li>\nHISCL CSF Based Test &#8211; Alzheimer&#8217;s Disease<\/li>\n<li>\nHISCL CSF Based Test &#8211; Alzheimer&#8217;s Disease Product Overview<\/li>\n<li>\nImmuno-flowFISH &#8211; Bone Marrow Cancer<\/li>\n<li>\nImmuno-flowFISH &#8211; Bone Marrow Cancer Product Overview<\/li>\n<li>\nImmuno-flowFISH Test &#8211; Leukaemia<\/li>\n<li>\nImmuno-flowFISH Test &#8211; Leukaemia Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; Bile Duct Cancer<\/li>\n<li>\nImmunochemistry Test &#8211; Bile Duct Cancer Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; CK19F<\/li>\n<li>\nImmunochemistry Test &#8211; CK19F Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; HAV Ab<\/li>\n<li>\nImmunochemistry Test &#8211; HAV Ab Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; HBc IgM<\/li>\n<li>\nImmunochemistry Test &#8211; HBc IgM Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; Tg Ab<\/li>\n<li>\nImmunochemistry Test &#8211; Tg Ab Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; TPO Ab<\/li>\n<li>\nImmunochemistry Test &#8211; TPO Ab Product Overview<\/li>\n<li>\nImmunochemistry Test &#8211; TR Ab<\/li>\n<li>\nImmunochemistry Test &#8211; TR Ab Product Overview<\/li>\n<li>\nLiquid Biopsy System<\/li>\n<li>\nLiquid Biopsy System Product Overview<\/li>\n<li>\nMinimally Invasive Postprandial Hyperglycemia Monitoring System<\/li>\n<li>\nMinimally Invasive Postprandial Hyperglycemia Monitoring System Product Overview<\/li>\n<li>\nMultiplex Gene Panel Test<\/li>\n<li>\nMultiplex Gene Panel Test Product Overview<\/li>\n<li>\nNext Generation Sequencing Based Companion Diagnostic Assay<\/li>\n<li>\nNext Generation Sequencing Based Companion Diagnostic Assay Product Overview<\/li>\n<li>\nNGS Analysis Software<\/li>\n<li>\nNGS Analysis Software Product Overview<\/li>\n<li>\nNon-Invasive Prenatal Test &#8211; Down&#8217;s Syndrome<\/li>\n<li>\nNon-Invasive Prenatal Test &#8211; Down&#8217;s Syndrome Product Overview<\/li>\n<li>\nOGT SLE Test<\/li>\n<li>\nOGT SLE Test Product Overview<\/li>\n<li>\nOncoBEAM &#8211; Hepatocellular Carcinoma<\/li>\n<li>\nOncoBEAM &#8211; Hepatocellular Carcinoma Product Overview<\/li>\n<li>\nOncoBEAM &#8211; Pancreatic Cancer<\/li>\n<li>\nOncoBEAM &#8211; Pancreatic Cancer Product Overview<\/li>\n<li>\nProtein Biomarker Assay &#8211; Prostate Cancer<\/li>\n<li>\nProtein Biomarker Assay &#8211; Prostate Cancer Product Overview<\/li>\n<li>\nqUTI<\/li>\n<li>\nqUTI Product Overview<\/li>\n<li>\nScreening System &#8211; Cervical Cancer<\/li>\n<li>\nScreening System &#8211; Cervical Cancer Product Overview<\/li>\n<li>\nSysmex XR-1000 Hematology Analyzer<\/li>\n<li>\nSysmex XR-1000 Hematology Analyzer Product Overview<\/li>\n<li>\nSysmex XR-2000 Hematology Analyzer<\/li>\n<li>\nSysmex XR-2000 Hematology Analyzer Product Overview<\/li>\n<li>\nSysmex XS-1000i AutoLoader Automated Hematology Analyzer &#8211; IG% Assay<\/li>\n<li>\nSysmex XS-1000i AutoLoader Automated Hematology Analyzer &#8211; IG% Assay Product Overview<\/li>\n<li>\nSysmex XS-1000i Automated Hematology Analyzer &#8211; IG% Assay<\/li>\n<li>\nSysmex XS-1000i Automated Hematology Analyzer &#8211; IG% Assay Product Overview<\/li>\n<li>\nSysmex Corp &#8211; Key Competitors<\/li>\n<li>\nSysmex Corp &#8211; Key Employees<\/li>\n<li>\nSysmex Corp &#8211; Key Employee Biographies<\/li>\n<li>\nSysmex Corp &#8211; Locations And Subsidiaries<\/li>\n<li>\nHead Office<\/li>\n<li>\nOther Locations &amp; Subsidiaries<\/li>\n<li>\nJoint Venture<\/li>\n<li>\nRecent Developments<\/li>\n<li>\nAppendix<\/li>\n<\/ul>\n<p>\nFor more information about this company profile visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5655753\/sysmex-corp-6869-product-pipeline-analysis?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=3sbz55&amp;utm_campaign=2125100+-+Sysmex+Corp+(6869)+Product+Pipeline+Analysis+Report+2025%3A+Haematology%2C+Haemostasis%2C+and+Urinalysis+Analyzers&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/mnnyae<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#105;&#x6c;&#x74;&#111;&#58;&#x70;&#x72;&#101;&#115;&#x73;&#x40;&#114;&#101;&#x73;&#x65;&#97;&#114;&#x63;&#x68;&#97;&#110;&#x64;&#x6d;&#97;&#114;&#x6b;&#x65;&#116;&#115;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow\" shape=\"rect\">&#x70;&#x72;&#101;&#115;s&#64;&#x72;&#x65;&#x73;&#101;ar&#x63;&#x68;&#x61;&#110;&#100;m&#x61;&#x72;&#x6b;&#101;&#116;s&#x2e;&#x63;&#x6f;&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Sysmex Corp (6869) &#8211; Product Pipeline Analysis, 2025 Update&#8221; company profile has been added to ResearchAndMarkets.com&#8217;s offering. This report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62427","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Sysmex Corp (6869) &#8211; Product Pipeline Analysis, 2025 Update&#8221; company profile has been added to ResearchAndMarkets.com&#8217;s offering. This report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-31T18:05:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2025-12-31T18:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/\"},\"wordCount\":1167,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231608490\\\/en\\\/2680175\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/\",\"name\":\"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231608490\\\/en\\\/2680175\\\/22\\\/logo.jpg\",\"datePublished\":\"2025-12-31T18:05:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231608490\\\/en\\\/2680175\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231608490\\\/en\\\/2680175\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Sysmex Corp (6869) &#8211; Product Pipeline Analysis, 2025 Update&#8221; company profile has been added to ResearchAndMarkets.com&#8217;s offering. This report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-31T18:05:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers &#8211; ResearchAndMarkets.com","datePublished":"2025-12-31T18:05:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/"},"wordCount":1167,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/","name":"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg","datePublished":"2025-12-31T18:05:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251231608490\/en\/2680175\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sysmex-corp-6869-product-pipeline-analysis-report-2025-haematology-haemostasis-and-urinalysis-analyzers-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62427"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62427\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}